Delivery Order SPE2DB20D1100-SPE2DB25FD8W7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamictal 25 mg tablets (100-count units) valued at $19,868.41 on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Lamictal 100 mg tablets (quantity 100) with a ceiling value of $27,252.70. This is a firm fixed price delivery order with no set-aside designation, executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical supply will be performed...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,579.11 to AmerisourceBergen Drug Corp for the supply of Lamictal 25 mg tablets (100 count) on July 22, 2025, with a completion date of July 23, 2025. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on July 28, 2025, to supply 60 tablets of Lamictal 150 mg with a ceiling value of $12,599.98. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 29, 2025. The contract serves as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lamictal (lamotrigine) 25 mg tablets in quantities of 100 units. This competitive, non-set-aside contract was executed on September 23, 2025, with a firm fixed price ceiling value of $3,822.90 and an ultimate completion date of September 24, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,047.16 to AmerisourceBergen Drug Corp for 60 tablets of Lamictal 150 mg on August 11, 2025, with completion scheduled for August 12, 2025. This delivery order was awarded on a firm fixed price basis without set-aside designation, indicating competitive award to this established pharmaceutical vendor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $42,766.34 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 200 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,178.43 fixed-price contract is for the delivery of 4,565,442,139 units of the prescription drug Lamictal 100 mg tablets. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen, as the prime contractor, will be responsible for supplying this critical medical commodity to the DLA to support...
- The Defense Logistics Agency awarded a $1,596.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Lamictal 100 mg, with performance in Conshohocken, Pennsylvania and completion by August 5, 2025. This delivery order represents a non-set-aside, competitively awarded transaction executed on August 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4,556,222,326 units of Lamictal 25 mg dispersible tablets. The total potential value of the order is $27,322.09, with a completion date of February 11, 2022. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products and...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD8W7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,622.55 to AmerisourceBergen Drug Corp for the supply of Lamictal 200 mg tablets (60-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child delivery order under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order represents a routine pharmaceutical supply transaction supporting military and federal healthcare systems. Lamictal (lamotrigine) is a neurological medication commonly used for seizure management and mood disorders, reflecting the critical medical supply needs served through AmerisourceBergen's extensive federal contract portfolio. As a prime vendor under the DLA's pharmaceutical supply chain, AmerisourceBergen Drug Corp maintains the capability to supply brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers through flexible contract vehicles designed to support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/6/25 |